TEMPS-A and Menopause Symptoms
Launched by BAGCILAR TRAINING AND RESEARCH HOSPITAL · May 12, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different personality traits might affect the symptoms women experience during menopause. It uses two questionnaires, the TEMPS-A and the MRS scales, to gather information from women who are going through the menopausal transition. The goal is to better understand the connection between a woman’s temperament and the symptoms she may face during this time.
To participate in the study, women need to be in certain stages of menopause called STRAW stages -1, +1a, or +1b. They should also be able to fill out questionnaires and give their consent to join. However, women who have had hormone therapy in the last six months, have undergone surgical menopause, or have serious physical or psychological health issues cannot take part. If eligible, participants can expect to complete some questionnaires and help researchers learn more about menopause and how it affects women differently. This study is currently looking for participants, so it’s a great opportunity to contribute to important research in this area.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women classified as STRAW stages -1, +1a, and +1b (menopausal transition stages)
- • Ability to complete questionnaires and provide informed consent
- Exclusion Criteria:
- • History of hormone therapy during the past 6 months
- • History of surgical menopause (bilateral oophorectomy)
- • Presence of severe physical disorders (e.g., malignancy, severe cardiovascular diseases)
- • Presence of severe psychological disorders (e.g., major depressive disorder, psychosis)
About Bagcilar Training And Research Hospital
Bagcilar Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical practices with comprehensive training programs for healthcare professionals. Its robust research framework facilitates the exploration of new treatments and therapies, ensuring that the latest scientific findings are translated into effective healthcare solutions. By fostering collaboration among multidisciplinary teams, Bagcilar Training and Research Hospital aims to contribute significantly to the global medical community and enhance health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Cemile Ilhan, MD
Principal Investigator
Bagcilar Training and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported